Clinical Trial Update: Evaluation of Meningococcal Immune Response Among Children Who Previously Received MenACWY Conjugate Vaccine [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating immune response to meningococcal vaccination in children who previously received a MenACWY conjugate vaccine; results were posted in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningococcal Meningitis

Drugs mentioned

• MenACWY Conjugate Vaccine (Meningococcal conjugate vaccine (serogroups A, C, W, Y))

Snippet

Sponsor: Novartis Vaccines | Conditions: Meningococcal Meningitis | Phase 3 | Status: COMPLETED | Results posted: 2014-05-14